Announcements
Trials
Browse
Landscape
Eligibility
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 1/2
×
Lymphoma
×
Ipilimumab
×
Clear all
Filters
3
NCT02681302
2025-07-25
CPIT001
Hackensack Meridian Health
Phase 1/2
Terminated
46 enrolled
13 charts
NCT03058289
2025-02-27
IT-01
Intensity Therapeutics, Inc.
Phase 1/2
Completed
111 enrolled
21 charts